Skip to content
2000
Volume 26, Issue 1
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Aims and Objectives: In our previous study, 21 sesquiterpenoids with different skeleton types were isolated from the radix of Curcuma aromatica Salisb., a traditional Chinese medicine used for treating depression and qi and blood stasis. C. aromatica enhanced PC12 cell viability upon damage by HO. The aim of this study was to elucidate the antioxidation capability of these sesquiterpenoids using a model of HO-induced PC12 cells and analyze the correlation between their structure and bio-activity. Materials and Methods: PC12 cells were simultaneously treated with 400 μM H2O2 and sesquiterpenoid compounds or vitamin E (used as a positive control) for 24 h. The activities of GSH-Px, LDH, CAT, and SOD were detected by ELISA kits. The reactive oxygen species (ROS) level in the cells was determined by the fluorescence probe DCFH-DA. [Ca2+]i was detected based on the Fluo 2-AM fluorescence labeling assay. The structures of sesquiterpenoids were featured with 41 selected molecular descriptors, and the relationship between active parameters and structural features was determined by the partial least squares (PLS) analysis. Results: All twenty-one sesquiterpenoids from the radix of C. aromatica increased the activities of GSH-Px, CAT, and SOD, and decreased the LDH leakage, and levels of ROS level and [Ca2+]i to different degrees. Some relationships were observed between the molecular descriptors featured by the sesquiterpenoids and GSH-Px, CAT, SOD, LDH, ROS, and [Ca2+]i by PLS analysis. Conclusions: Twenty-one sesquiterpenoids showed different antioxidation abilities as measured by a model of HO-induced PC12 cells. Five molecular descriptors were positively correlated with GSH-Px, CAT, SOD, and were negatively correlated with LDH and [Ca2+].

Loading

Article metrics loading...

/content/journals/cchts/10.2174/1386207325666220426081812
2023-01-01
2025-03-27
Loading full text...

Full text loading...

/content/journals/cchts/10.2174/1386207325666220426081812
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test